Skip to content

Outcomes of CPM Usage Following Arthroscopic Acetabular Labral Repair

The Effect of Continuous Passive Motion on Pain Control Following Hip Arthroscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03407612
Enrollment
54
Registered
2018-01-23
Start date
2013-02-15
Completion date
2015-06-25
Last updated
2020-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoro Acetabular Impingement, Hip Labral Tear, Pain, Postoperative

Keywords

continuous passive motion device, HOS-ADL, hip arthroscopy

Brief summary

The purpose of this study is to measure whether CPM (continuous passive motion) usage improves outcomes following arthroscopic hip surgery that includes labral repair. Investigators tested the hypothesis that CPM usage reduces pain levels and pain medication use and improves function in individuals who undergo hip arthroscopy.

Detailed description

Subjects undergoing primary hip arthroscopy for acetabular labral repair were randomized to determine whether they would receive a CPM. Those subjects receiving a CPM were instructed to use it for 4-6 hours daily throughout the first two postoperative weeks. The total number of pain medications and average pain scores over the two weeks, as well as Hip Outcome Score Activity of Daily Living (HOS ADL) scores at standard time points were compared via a two sample t-test and intention-to-treat analysis.

Interventions

CPM devices are used in postoperative rehabilitation and are throughout to reduce joint stiffness.

Sponsors

Ohio State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* undergoing hip arthroscopy to repair a torn labrum

Exclusion criteria

* pregnancy * revision surgery * bilateral surgery

Design outcomes

Primary

MeasureTime frameDescription
Change in Patient Satisfaction and Functional OutcomeBaseline and 6 weeks, 12 weeks, and 6 months postoperativelyHip Outcome Score Activities of Daily Living (HOS ADL) questionnaire completed at specific time points. Completion of the HOS ADL provides a score from 0 to 100, with a higher score corresponding to greater level of function. The improvement preoperative to 6 month postoperative scores was also computed.

Secondary

MeasureTime frameDescription
Analgesic UsageInitial two postoperative weeksAnalgesic usage measured via the morphine-equivalent dose of consumed analgesic medications
Pain LevelInitial two postoperative weeksChange in pain level measured on a Likert-type scale from 0 to 10, with higher scores representing higher pain levels.

Countries

United States

Participant flow

Participants by arm

ArmCount
CPM Used
These subjects received a continuous passive motion (CPM) device and were instructed to use it for 4-6 hours daily throughout the first two postoperative weeks following their arthroscopic labral repair. They were provided adequate education on how to operate the device. The subjects recorded their average usage of the CPM, as well as their personal perception of the CPM, at the postoperative 2 day, 7 day, and 14 day marks. Continuous Passive Motion: CPM devices are used in postoperative rehabilitation and are throughout to reduce joint stiffness.
19
No CPM Used
No CPM was administered to these subjects.
23
Total42

Baseline characteristics

CharacteristicNo CPM UsedTotalCPM Used
Age, Continuous29.5 years
STANDARD_DEVIATION 11.1
32.5 years
STANDARD_DEVIATION 11.3
36.2 years
STANDARD_DEVIATION 10.7
BMI25.1 kg/m^2
STANDARD_DEVIATION 4.6
26.2 kg/m^2
STANDARD_DEVIATION 5.8
27.5 kg/m^2
STANDARD_DEVIATION 7
Hand Dominance
Left Handed
10 Participants18 Participants8 Participants
Hand Dominance
Right Handed
13 Participants24 Participants11 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
23 participants42 participants19 participants
Sex: Female, Male
Female
20 Participants38 Participants18 Participants
Sex: Female, Male
Male
3 Participants4 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 190 / 23
serious
Total, serious adverse events
0 / 190 / 23

Outcome results

Primary

Change in Patient Satisfaction and Functional Outcome

Hip Outcome Score Activities of Daily Living (HOS ADL) questionnaire completed at specific time points. Completion of the HOS ADL provides a score from 0 to 100, with a higher score corresponding to greater level of function. The improvement preoperative to 6 month postoperative scores was also computed.

Time frame: Baseline and 6 weeks, 12 weeks, and 6 months postoperatively

ArmMeasureGroupValue (MEAN)Dispersion
CPM UsedChange in Patient Satisfaction and Functional Outcome6 weeks postoperative74.6 units on a scaleStandard Deviation 14.8
CPM UsedChange in Patient Satisfaction and Functional Outcome6 months postoperative81.9 units on a scaleStandard Deviation 16.4
CPM UsedChange in Patient Satisfaction and Functional Outcome12 weeks postoperative81.1 units on a scaleStandard Deviation 14.6
CPM UsedChange in Patient Satisfaction and Functional OutcomeImprovement17.0 units on a scaleStandard Deviation 16
CPM UsedChange in Patient Satisfaction and Functional OutcomePreoperative64.5 units on a scaleStandard Deviation 11.6
No CPM UsedChange in Patient Satisfaction and Functional OutcomeImprovement20.2 units on a scaleStandard Deviation 15.3
No CPM UsedChange in Patient Satisfaction and Functional OutcomePreoperative62.7 units on a scaleStandard Deviation 15
No CPM UsedChange in Patient Satisfaction and Functional Outcome6 weeks postoperative72.8 units on a scaleStandard Deviation 12.5
No CPM UsedChange in Patient Satisfaction and Functional Outcome12 weeks postoperative81.5 units on a scaleStandard Deviation 11.4
No CPM UsedChange in Patient Satisfaction and Functional Outcome6 months postoperative82.8 units on a scaleStandard Deviation 12.8
Comparison: This analysis considers the baseline HOS-ADL measures.p-value: 0.67t-test, 2 sided
Comparison: This analysis considers the 6 week postoperative HOS-ADL measures.p-value: 0.73t-test, 2 sided
Comparison: This analysis considers the 12 week postoperative HOS-ADL measures.p-value: 0.87t-test, 2 sided
Comparison: This analysis considers the 6 month postoperative HOS-ADL measures.p-value: 0.78t-test, 2 sided
Secondary

Analgesic Usage

Analgesic usage measured via the morphine-equivalent dose of consumed analgesic medications

Time frame: Initial two postoperative weeks

ArmMeasureValue (MEAN)Dispersion
CPM UsedAnalgesic Usage239 morphine equivalent dosesStandard Deviation 269
No CPM UsedAnalgesic Usage330 morphine equivalent dosesStandard Deviation 227
p-value: 0.25t-test, 2 sided
Secondary

Pain Level

Change in pain level measured on a Likert-type scale from 0 to 10, with higher scores representing higher pain levels.

Time frame: Initial two postoperative weeks

ArmMeasureValue (MEAN)Dispersion
CPM UsedPain Level2.94 units on a scaleStandard Deviation 2
No CPM UsedPain Level4.23 units on a scaleStandard Deviation 2
p-value: 0.04t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026